Managed Access Programs

icon-map

The FarmaMondo Group supports biopharmaceutical companies in the supply of products to patients in markets where it has not been commercially launched yet, through the implementation of Managed Access Programs, including Named Patient Supply services in more than 80 markets.

Being a preferred provider of Unlicensed Medicines to thousands of HCPs globally seeking ethical access to yet commercially unavailable therapies in their markets, the Group’s network and geographical footprint supports wider access options for the Biopharma.

The Group offers both paid access and no-charge (compassionate) access Programs through a comprehensive service package with a fair financial structure and flexible service terms.

Currently the Group operates the following Programs across various geographic regions. For more information please contact FarmaMondo offices in your region.

Therapeutic Area Indications Geographical Scope
CardiovascularAcute Ischemic StrokeTargeted regions/countries
Acute Myocardial infarctionTargeted regions/countries
Arterial HypertensionTargeted regions/countries
Idiopathic or heritable pulmonary arterial hypertension (PAH)Targeted regions/countries
Hematology OrphanParoxysmal Nocturnal Hemoglobinuria (PNH)Targeted regions/countries
Infectious Diseases & VirologyViral CMV retinitis; Mucocutaneous Acyclovir Resistant HSV InfectionsTargeted regions/countries
HIVGlobal
Metabolic Disease OrphanWilson's disease (orphan)Targeted regions/countries
Congenital Generalized LipodystrophyTargeted regions/countries
Homozygous Familial HypercholesterolemiaTargeted regions/countries
Gaucher DiseaseGlobal
Alagille syndrome (ALGS)Targeted regions/countries
Progressive familial intrahepatic cholestasis (PFIC)Targeted regions/countries
Nephrology OrphanAtypical Hemolytic Uremic Syndrome (aHUS)Global
Duchenne Muscular DystrophyTargeted regions/countries
NeurologyEpilepsyTargeted regions/countries
OncologyEpithelial ovarian cancer / fallopian tube cancerTargeted regions/countries
Chemotherapy induced neutropeniaTargeted regions/countries
Onco-haematologyAcute Promyelocytic LeukemiaTargeted regions/countries
Multiple myeloma, melanoma, amyloidosis, sarcomaTargeted regions/countries
Acute Lymphoblastic Leukemia (ALL)Global
Ophthalmology OrphanNeurotrophic KeratitisTargeted regions/countries
Pediatric OncologyNeuroblastomaTargeted regions/countries
TransplantationConditioning agent for bone marrow transplantationTargeted regions/countries

PLEASE CONTACT US FOR FURTHER QUESTIONS AND INFORMATION

  • If you would like to send us a general enquiry, please complete the following form.